Highlights AcouSort AB

Equities

ACOU

SE0009189608

Market Closed - Nasdaq Stockholm Other stock markets 08:59:45 20/05/2024 pm IST			5-day change	1st Jan Change
10.2 ^SEK	-0.49%		-6.42%	-34.41%

02/05	AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation	CI
29/04	AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation	02/05	CI
AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing	29/04	CI
AcouSort Initiates Two AcouWash Lease Collaborations with Potential OEM Partners	26/04	CI
AcouSort AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
AcouSort AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11	CI
AcouSort Delivers Fully Functional Test System for Automated Cell Handling Within Cell Therapy	16/23/16	CI
AcouSort AB Delivers and Installed an AcouWash System At the Faculty of Medicine At the University of Porto, Portugal	19/23/19	CI
AcouSort AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/23/24	CI
AcouSort's Cell Therapy Partnership Enters Evaluation Phase	05/23/05	MT
AcouSort AB Announces Cell Therapy Collaboration with Leading Global Life Science Company Continues to Expand	05/23/05	CI
AcouSort AB Delivers Unique Acouwash 2 System to Lund University	07/23/07	CI
AcouSort AB Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31	CI
AcouSort AB Launches Next Generation AcouTrap at CYTO 2023	22/23/22	CI
AcouSort AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	22/23/22	CI
Medtech Group AcouSort Extends Collaboration on Cell Therapies	20/23/20	MT
AcouSort, BlueCell Near Stem Cell Therapy Project Completion	19/23/19	MT
AcouSort AB and the Biowings Project Creates New Opportunities for Large-Scale Production and Exosome-Based Diagnostics	01/22/01	CI
AcouSort AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23/22/23	CI
AcouSort Enters Cell Therapy Partnership with Global Life Science Company	14/22/14	MT
AcouSort Expands Its Cell Therapy Efforts and Enters Collaboration with Global Life Science Company	14/22/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AcouSort AB

Equities

ACOU

SE0009189608

Highlights

Filters